Year-two follow-up results of an observational study conducted in Crohn's disease and ulcerative colitis patients treated with infliximab biosimilar CT-P13 in a real-life setting

被引：0
|
作者：
Laharie, D. [1 ]
Pierron, G. [2 ]
Brault, Y. [3 ]
Bouhnik, Y. [4 ]
Nancey, S. [5 ,6 ]
机构：
[1] Univ Hosp Ctr Bordeaux, Dept Gastroenterol, Bordeaux, France
[2] Pfizer, Inflammat & Immunol, Paris, France
[3] Pfizer, Stat, Paris, France
[4] Paris IBD Ctr, Grp Hosp Prive Ambroise Pare Hartmann, Neuilly Sur Seine, France
[5] Lyon South Hosp Pierre Benite, Lyon, France
[6] INSERM, U1111 CIRI, Dept Gastroenterol, Lyon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P529
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [1] Year-two Follow-up Results of an Observational Study Conducted in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Patients Treated with Infliximab Biosimilar CT-P13 in a Real-life Setting
    Fautrel, Bruno
    Assing, Maryse
    Mammar, Nadir
    Brault, Yves
    Marotte, Hubert
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2810 - 2812
  • [2] A French nationwide prospective study on patients with Crohn's disease and ulcerative colitis treated with Infliximab-biosimilar CT-P13 in a real-life setting: two-year follow-up of the ReFLECT study
    Bouhnik, Y.
    Nancey, S.
    Assing, M.
    Mammar, N.
    Laharie, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S320 - S321
  • [3] Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis
    Gheorghe, Cristian
    Svoboda, Pavel
    Mateescu, Bogdan
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 129 - 134
  • [4] Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis
    Keil, Radan
    Wasserbauer, Martin
    Zadorova, Zdena
    Hajer, Jan
    Drastich, Pavel
    Wohl, Pavel
    Benes, Marek
    Bojkova, Martina
    Svoboda, Pavel
    Konecny, Michal
    Falt, Premysl
    Vanasek, Tomas
    Pesta, Martin
    Pesek, Frantisek
    Bouchner, Ludek
    Kozeluhova, Jana
    Novotny, Ales
    Bartuskova, Lucie
    Spicak, Julius
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1062 - 1068
  • [5] Effectiveness and safety of biosimilar infliximab (remsima) in a real-life setting in 84 patients with Crohn's disease and ulcerative colitis
    Gheorghe, C.
    Svoboda, P.
    Dimitriu, A.
    Mateescu, B.
    Kotzev, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S316 - S317
  • [6] A novel subcutaneous infliximab (CT-P13): 1-year results including switching results from intravenous infliximab (CT-P13) in patients with active Crohn's disease and ulcerative colitis
    Ben-Horin, S.
    Leszczyszyn, J.
    Dudkowiak, R.
    Lahat, A.
    Gawdis-Wojnarska, B.
    Pukitis, A.
    Horynski, M.
    Farkas, K.
    Kierkus, J.
    Kowalski, M.
    Ye, B. D.
    Reinisch, W.
    Lee, S. J.
    Kim, S. H.
    Kim, M. R.
    Kim, Y. A.
    Kim, H. N.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S021 - S022
  • [7] An observational, prospective cohort study to evaluate the long term safety and effectiveness of intravenous CT-P13 (biosimilar of infliximab) in patients with Crohn's Disease or Ulcerative Colitis
    Cheon, J. H.
    Kang, H. W.
    Lee, S. J.
    Kim, S. H.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S378 - S378
  • [8] Population pharmacokinetics of subcutaneous infliximab CT-P13 in Crohn's disease and ulcerative colitis
    Hanzel, Jurij
    Bukkems, Laura H.
    Gecse, Krisztina B.
    D'Haens, Geert R.
    Mathot, Ron A. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1309 - 1319
  • [9] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [10] INFLIXIMAB ORIGINATOR, INFLIXIMAB BIOSIMILAR AND ADALIMUMAB ARE EQUALLY EFFECTIVE AND SAFE IN ULCERATIVE COLITIS AND CROHN'S DISEASE - A REAL-LIFE COHORT STUDY
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Rovigo, L.
    Marinelli, C.
    Massimi, D.
    Gubbiotti, A.
    Ghisa, M.
    Lorenzon, G.
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S130 - S131
12345